Lung cancer is the leading cause of cancer-related death in the United States. An estimated
219,440 new cases (116,090 men; 103,350 women) of lung and bronchus cancer were …

Purpose This study compared treatment outcomes of stereotactic body radiation therapy
(SBRT) with those of surgery in stage I non-small cell lung cancer (NSCLC). Methods and …

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC)
is lobectomy with mediastinal lymph node dissection or sampling. Stereotactic ablative …

Context Patients with early stage but medically inoperable lung cancer have a poor rate of
primary tumor control (30%-40%) and a high rate of mortality (3-year survival, 20%-35%) …

PURPOSE: The 50-month results of a prospective Phase II trial of stereotactic body radiation
therapy (SBRT) in medically inoperable patients are reported. METHODS AND MATERIALS …

Purpose Stereotactic body radiotherapy (SBRT) for stage I non–small-cell lung cancer
(NSCLC) is associated with high local control rates. The impact of introducing SBRT in …

This report from the Stereotactic Radiotherapy Working Group of the German Society of
Radiation Oncology (Deutschen Gesellschaft für Radioonkologie, DEGRO) provides a …

PURPOSE: High local control rates can be achieved using stereotactic radiotherapy in
Stage I non–small-cell lung cancer (NSCLC), but reports have suggested that toxicity may …

Rationale: Screening for lung cancer with modern imaging technology may decrease lung
cancer mortality, but encouraging results have only been obtained in uncontrolled studies …

Lung Cancer Screening in: Journal of the National Comprehensive Cancer Network Volume
10 Issue 2 (2012) Jump to Content User Account Sign In to save searches and organize your …